Healthcare provider profile · identity verified

Nayle Romero

Family Practice · MIAMI, FL · NPI 1912548827

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	919	193
Vitamin D2	Ergocalciferol (Vitamin D2)	642	104
Losartan Potassium	Losartan Potassium	627	130
Alendronate Sodium	Alendronate Sodium	616	95
Metformin Hcl	Metformin Hcl	562	111
Atorvastatin Calcium	Atorvastatin Calcium	534	154
Albuterol Sulfate Hfa	Albuterol Sulfate	432	119
Omeprazole	Omeprazole	408	88
Donepezil Hcl	Donepezil Hcl	405	69
Lisinopril	Lisinopril	403	87
Rosuvastatin Calcium	Rosuvastatin Calcium	393	121
Famotidine	Famotidine	381	75
Simvastatin	Simvastatin	379	105
Amlodipine Besylate	Amlodipine Besylate	373	82
Folic Acid	Folic Acid	363	60
Montelukast Sodium	Montelukast Sodium	363	89
Pantoprazole Sodium	Pantoprazole Sodium	343	73
Levothyroxine Sodium	Levothyroxine Sodium	281	58
Metoprolol Succinate	Metoprolol Succinate	280	58
Hydrochlorothiazide	Hydrochlorothiazide	260	60
Memantine Hcl	Memantine Hcl	239	49
Temazepam	Temazepam	229	43
Escitalopram Oxalate	Escitalopram Oxalate	226	47
Tamsulosin Hcl	Tamsulosin Hcl	225	49
Ezetimibe	Ezetimibe	211	38
Azithromycin	Azithromycin	173	138
Clopidogrel	Clopidogrel Bisulfate	168	37
Metoprolol Tartrate	Metoprolol Tartrate	168	35
Trazodone Hcl	Trazodone Hcl	151	33
Mirtazapine	Mirtazapine	148	35
Glipizide	Glipizide	142	30
Sildenafil Citrate	Sildenafil Citrate	131	21
Benzonatate	Benzonatate	130	105
Fenofibrate	Fenofibrate	128	20
Saxagliptin Hcl	Saxagliptin Hcl	126	17
Dapagliflozin	Dapagliflozin Propanediol	123	20
Allopurinol	Allopurinol	119	24
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	116	14
Quetiapine Fumarate	Quetiapine Fumarate	111	21
Citalopram Hbr	Citalopram Hydrobromide	108	24
Enalapril Maleate	Enalapril Maleate	108	23
Carvedilol	Carvedilol	107	21
Sertraline Hcl	Sertraline Hcl	106	22
Glimepiride	Glimepiride	102	20
Pentoxifylline	Pentoxifylline	102	16
Atenolol	Atenolol	101	23
Furosemide	Furosemide	101	30
Alprazolam	Alprazolam	94	27
Latanoprost	Latanoprost	93	19
Fluticasone Propionate	Fluticasone Propionate	92	45
Carbidopa-Levodopa	Carbidopa/Levodopa	87	16
Clonazepam	Clonazepam	87	22
Dicyclomine Hcl	Dicyclomine Hcl	86	29
Prednisone	Prednisone	78	62
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	21
Finasteride	Finasteride	75	17
Ketoconazole	Ketoconazole	74	24
Baclofen	Baclofen	73	57
Methocarbamol	Methocarbamol	72	58
Chlorthalidone	Chlorthalidone	71	18
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	71	11
Hydralazine Hcl	Hydralazine Hcl	71	14
Tradjenta	Linagliptin	69	suppressed
Levetiracetam	Levetiracetam	68	12
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	67	19
Tadalafil	Tadalafil	66	15
Methylprednisolone	Methylprednisolone	65	60
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	64	27
Triamcinolone Acetonide	Triamcinolone Acetonide	61	32
Diclofenac Sodium	Diclofenac Sodium	58	49
Trueplus Pen Needle	Pen Needle, Diabetic	58	suppressed
Torsemide	Torsemide	54	suppressed
Mupirocin	Mupirocin	53	37
Pioglitazone Hcl	Pioglitazone Hcl	53	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Glipizide Er	Glipizide	48	suppressed
Eliquis	Apixaban	46	suppressed
Meclizine Hcl	Meclizine Hcl	46	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	43	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	43	12
Meloxicam	Meloxicam	42	39
Propranolol Hcl	Propranolol Hcl	42	suppressed
Buspirone Hcl	Buspirone Hcl	41	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	40	38
Ammonium Lactate	Ammonium Lactate	39	17
Clobetasol Propionate	Clobetasol Propionate	37	suppressed
Potassium Chloride	Potassium Chloride	37	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	36	suppressed
Irbesartan	Irbesartan	36	suppressed
Repaglinide	Repaglinide	36	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	36	suppressed
Ciclopirox	Ciclopirox	35	16
Silver Sulfadiazine	Silver Sulfadiazine	35	19
Azelastine Hcl	Azelastine Hcl	34	15
Zolpidem Tartrate	Zolpidem Tartrate	34	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	33	13
Cilostazol	Cilostazol	32	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	32	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	32	28
Ibuprofen	Ibuprofen	31	24
Nitroglycerin	Nitroglycerin	31	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	31	suppressed
Trueplus Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	30	suppressed
Verapamil Hcl	Verapamil Hcl	28	suppressed
Xarelto	Rivaroxaban	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	27	25
Solifenacin Succinate	Solifenacin Succinate	27	suppressed
Sucralfate	Sucralfate	27	suppressed
Warfarin Sodium	Warfarin Sodium	27	suppressed
Diltiazem Hcl	Diltiazem Hcl	26	suppressed
Pravastatin Sodium	Pravastatin Sodium	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Alogliptin	Alogliptin Benzoate	25	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Bumetanide	Bumetanide	25	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	25	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Brilinta	Ticagrelor	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Celecoxib	Celecoxib	23	21
Januvia	Sitagliptin Phosphate	23	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	23	suppressed
Tramadol Hcl	Tramadol Hcl	21	15
Lactulose	Lactulose	20	12
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	19	12
Methimazole	Methimazole	19	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	19	16
Colchicine	Colchicine	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Nystatin	Nystatin	18	suppressed
Amoxicillin	Amoxicillin	17	14
Nitrofurantoin	Nitrofurantoin Macrocrystal	17	16
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	16	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	16	suppressed
Hydrocortisone	Hydrocortisone	16	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	16	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Methotrexate	Methotrexate Sodium	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Primidone	Primidone	15	suppressed
Tiotropium Bromide	Tiotropium Bromide	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Levofloxacin	Levofloxacin	14	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Novolog Mix 70-30	Insulin Aspart Prot/Insuln Asp	14	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	14	suppressed
Thioridazine Hcl	Thioridazine Hcl	14	suppressed
Verapamil Er	Verapamil Hcl	14	suppressed
Acyclovir	Acyclovir	13	suppressed
Cephalexin	Cephalexin	13	13
Diclofenac Potassium	Diclofenac Potassium	13	11
Erythromycin	Erythromycin Base	13	12
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	13
Timolol Maleate	Timolol Maleate	13	suppressed
Unifine Pentips	Pen Needle, Diabetic	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Brimonidine Tartrate-Timolol	Brimonidine Tartrate/Timolol	12	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	12	suppressed
Icosapent Ethyl	Icosapent Ethyl	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	12	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	12	suppressed
Ramipril	Ramipril	12	suppressed
Terazosin Hcl	Terazosin Hcl	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	12	suppressed
Glyburide	Glyburide	11	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	11	suppressed
Ssd	Silver Sulfadiazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error